Acute myeloid leukemia trials in Malaysia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Where

  Johor Bahru, Kuala Lumpur, Petaling Jaya, Subang Jaya

  Age

  12 years and over

  People

  468 worldwide

  Run by

  Syndax Pharmaceuticals

  See details and how to joinNCT07211958 · EU 2025-522279-27-00